What is a known side effect of Daliresp?

Daliresp, known generically as roflumilast, is a medication prescribed primarily for the management of chronic obstructive pulmonary disease (COPD). One of the recognized side effects of Daliresp is weight loss.

Weight loss may occur due to several factors associated with how the drug works in the body. Daliresp functions as a phosphodiesterase-4 inhibitor, which can lead to reduced inflammation in the lungs. However, the mechanism by which it achieves this can also affect appetite and metabolism, potentially leading to a decrease in body weight over time.

Although weight gain, hypertension, and increased heart rate are concerns with other medications, they are not commonly associated with Daliresp. Understanding the side effect profile of medications like Daliresp is crucial for monitoring patients effectively and ensuring their well-being while on treatment.